Currently browsing tag

priority-killer

Health specialists call for $2 billion global fund for vaccines

Global health experts called on Wednesday for the creation of a $2 billion vaccine development fund to feed a pipeline of potential new shots against priority killer diseases like Ebola, MERS and the West Nile virus. The fund would help bridge the gap between early stage drug discovery work carried out at universities and small biotech firms, and the late stage development and large-scale clinical trials needed to get a new vaccine to market. “We can no longer sit back and ignore the chronic lack of progress in developing new vaccines, and improving existing ones,” said Jeremy Farrar, director of the Wellcome Trust global health charity, who co-wrote a paper calling for the creation of such a fund.